Adherium (ASX:ADR) said it has received firm commitments for AU$2.6 million convertible notes to support the roll-out of its proprietary Hailie Smartinhaler platform in the US, according to a Tuesday Australian bourse filing.

The capital raise is expected to issue 2.6 million convertible notes maturing in nine months at an interest of 10% per year. Participants will also receive one attached option per two shares subscribed.

PAC Partners and Stralis Capital were the joint lead managers for the capital raise.

The company reaffirmed its guidance to onboard another 1,800 active patients during the next six months and 9,000 active patients by the end of the year.

Its shares rose 10% on market close.